Quality of life and associated factors in individuals with schizophrenia undergoing treatment in a day-hospital: the experience of a psychiatric center in northeastern Brazil
DOI:
https://doi.org/10.33448/rsd-v11i7.29084Keywords:
Quality of Life; Schizophrenia; WHOQoL-Bref.Abstract
Schizophrenia is a serious and persistent disorder. It has different consequences in the behavioral, emotional, cognitive, functional and social spheres, interfering in the quality of life (Qol) of individuals. OBJECTIVE: to describe the quality of life in individuals undergoing treatment for schizophrenia in a day hospital, verifying the association with sociodemographic, diagnostic and therapeutic characteristics. METHODOLOGY: cross-sectional study with 62 individuals diagnosed with schizophrenia, on a daily hospital regimen. A sociodemographic and diagnostic and therapeutic characterization questionnaire and the WHOQoL-bref were applied. The means of the physical, psychological, social and environmental domains and the percentage of the qoL category "needs to improve" between sociodemographic, diagnostic and therapeutic variables were compared. RESULTS: in the sample with a mean (SD) age of 42.4 (11.1) years, predominance of men (61.2%), schooling above 8 years (95.2%) and self-declared white (59.7%), it was observed that the diagnosis prevailed in adulthood (8 5.5%), with more than 3 hospitalizations (37.1%) and the use of long-action neuroleptics (45.1%). Quality of life was more compromised for the physical (p=0.027) and psychological (p=0.022) domains among women. Singles/divorced had worse quality of life in the physical (p=0.006) and psychological (p=0.017) domains. Those using long-action neuroleptics had better quality of life scores in the psychological domain (p=0.021). CONCLUSION: there was a worse perception of quality of life among women, people without a partner, with fixed income and who did not use long-action neuroleptics.
References
Aykut, D. S. (2019). Comparison of paliperidone palmitate and second-generation oral antipsychotics in terms of medication adherence, side effects, and quality of life. Journal of clinical psychopharmacology. 39 (1), 57-62.
Brasil. M. S. (2009). Secretaria de Atenção à Saúde. Política Nacional de Humanização da Atenção e Gestão do SUS. Clínica ampliada e compartilhada. Brasília.
Cardoso, C. S., Caiaffa, W. T., Bandeira, M., Siqueira, A. L., Abreu, M. N. S. & Fonseca, J. O. P. (2005). Factors associated with low quality of life in schizophrenia. Cadernos de Saúde Pública. 21, 1338-1340.
Cardoso, C. S., Caiaffa, W. T., Bandeira, M., Siqueira, A. L., Abreu, M. N. S., & Fonseca, J. O. P. (2006). Qualidade de vida e dimensão ocupacional na esquizofrenia: uma comparação por sexo. Cadernos de Saúde Pública. 22(6), 1303-1314.
Chan, S., YU, I. W. (2004). Quality of life of clients with schizophrenia. J Adv Nurs. 45(1), 72-83.
Chang, C., Yong-Chen, H., & Yang, P. (2021). Improving of Cognition and Quality of Life in Schizophrenia With One-month and Three-month Paliperidone Palmitate Treatment. Research Square. 1, 1-16.
Fleck, M.P., Louzada, S., Xavier, M., Chamovich, E., Vieira, G., & Santos, L. Pinzon, V. (2000). Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida “WHOQOL-bref”. Revista de saúde pública. 34(2), 178-183.
Galuppi, A., Turola, M.C., Nanni, M.G. Mazzoni, P., & Grassi, L. (2010). Schizophrenia and quality of life: how important are symptoms and functioning?. Int J Ment Health Syst. 4, 31- 31.
Geeskeet, V. R., Rooijen, M. V., Maat, a., Vermeuleen, J. M., Meijer, C. J., Ruhé, H. G., & Haan, l. (2019). Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling. Schizophrenia Research. 208, 82-89.
Grigolato, T., Chagas, M. H. N., Trzesniak, C., Crippa, J. A. S., Hallak, J. E. C., & Santos, J. L. F. (2014). A influência dos papéis sociais na qualidade de vida de portadores de esquizofrenia. Cadernos de Terapia Ocupacional da UFSCar. 22(1), 195-203.
Haraldstad, K,. Wahl, A,. Andenæs , R., Andersen, J R., Andersen, M H., Beisland, E., Borge, C. R., Engebretsen, E., Eisemann, M., Halvorsrud, L., Hanssen, T. A., Haugstvedt , A., Haugland , T., Johansen , V. A.; Larsen , M.H., Løvereide, L., Løyland, B., Kvarme, L. G.; Moons, P., Norekvål, T.M., Ribu,L., Rohde, G. E.; Urstad, K.H., & Helseth, S. (2019). A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 28, 2641–2650.
Heckers, S., Barch, D. M., Bustillo, J., Gaebel, W., Gur, R., Malaspina, D., Owen, M. J., Schultz, S., Tandon, R.. Tsuang, M., Os, J. V., & Carpenter, W. (2013). Structure of the psychotic disorders classification in DSM‐5. Schizophrenia Research. 150, 11–14.
Heider, D., Aangermmeyer, M.C., Winkler, I., Schomerus, G., Bebbington, P.E., Brugha, T., Azorin, J.M., & Toumi, M. (2007). A prospective study of Quality of life in schizophrenia in three European countries. Schizophrenia Research. 93(1-3), 194-202.
Hofer, A., Baumgartner, S., Edlinger, M., Hummer, M., Kemmler, G., Rettebacher, M.A., Schweigkofler, H., Schwitzer, J., & Fleischhacker, W.W. (2005). Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. European Psychiatry. 20(5-6), 386-394.
Harrison & G. W. Roberts (Eds.), The neuropathology of schizophrenia. Progress and interpretation. Oxford University Press. 179(5), 472-473.
Katschnig, H. (2000). Schizophrenia and quality of life. Acta Psychiatrica Scandinavica. 102(407), 33-37.
Malta M, Cardoso L.O., Bastos F.I., Magnanini, M.M., & Silva, C.M. (2010). STROBE initiative: guidelines on reporting observational studies. Rev Saude Publica. 44(3), 559-65.
Matos, G., Guarnieiro, F., Hallak, J. E., & Bressan, R. A. (2015). Schizophrenia, the forgotten disorder: the scenario in Brazil. Rev. Bras. Psiquiatr. 37 (4), 269-270.
Mckenna, P. J. (2007). Schizophrenia and Related Syndromes. (2nd ed.). Routledge.
Mccutcheon R.A., Reis, M. T., & Howes O. D. (2019). Schizophrenia An Overview. JAMA Psychiatry. 77(2), 201-210
Meijer, C.J., Koeter, M.W., Sprangers, M.A., & Schene, A.H. (2009). Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology. 44(5), 361-368.
Moraes, D. G., & Cordeiro, E. L. (2013). Qualidade de vida dos usuários com esquizofrenia atendidos por centros de atenção psicossocial. Journal of Nursing UFPE/Revista de Enfermagem UFPE. 7(10), 6130-6138.
Moergades-Bamba, C.I., Fuster-Ruizdeapodaca, M. J., & Molero, F. (2019) Estigma internalizado e seu impacto na qualidade de vida da esquizofrenia. Psicologia, Saúde e Medicina. 24(8), 992-1004.
Narvaez, J.M., Twamley, E.W., McKibbin, C.L., Heaton, R.K., & Patterson, T.L. (2008). Subjective and objective quality of life in schizophrenia. Schizophrenia Research, 98, 201-208.
Organização Mundial da Saúde. (1996) Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde: CID-10 Décima revisão. Trad. do Centro Colaborador da OMS para a Classificação de Doenças em português. 3 ed. São Paulo: EDUSP.
Pereira, E.F., Teixeira, C.S., & Santos, A. (2012). Qualidade de vida: abordagens, conceitos e avaliação. Rev. Bras. Educ. Fís. Esporte. 26(2) 241-50.
Russo, M., Jovanovic, N., Uka, F; Konjufca, J., Berxulli, D., & Arenliu, A. (2022). Women with schizophrenia have worse clinical presentation compared to their men counterpart in Kosovo: a cross-sectional study. Global psychiatry archives. 5(1), 42-50.
Shaun, M, E., & Cristina, E. N. (2007). Psychiatric Symptoms and Quality of Life in Schizophrenia: A Meta-Analysis, Schizophrenia Bulletin. 33(5), 1225–1237.
Silva, A. F. O., Dias, E. E. C., & Silva, R. L. A. S. (2022). Calidad de vida: una reflexión sobre la ciudad de SÃO PAULO. Revista Saúde e Meio Ambiente- UFMS- Campus Três Lagoas RESMA. 14(1), 01-15
Silva, R. C. B. (2006). Esquizofrenia: uma revisão. Psicol. USP. 17(4), 263-285.
Silva, R.C., Pereira, A.D., & Moura, E.P. (2020). Qualidade de Vida e Transtornos Mentais Menores dos Estudantes de Medicina do Centro Universitário de Caratinga (UNEC) - Minas Gerais. Rev. Bras. Educ. Med. 44(2), 1-7.
Souza, L. A., & Coutinho, E. S. F. (2006). Fatores associados à qualidade de vida de pacientes com esquizofrenia. Brazilian Journal of Psychiatry. 28(1), 50-58.
Sousa, D., De Pinho, L. G., & Pereira, A. (2017). Qualidade de vida e suporte social em doentes com esquizofrenia. Psicologia, Saúde e Doenças. 18(1), 91-101.
Tamminga, C A. (1997) Gender and schizophrenia. Journal of Clinical Psychiatry. 58(15), 33-37.
The WHOQOL Group. (1995). The word Health Organization Quality of Life Assessment (WHOQOL): Position paper from the Health Organization. Soc. Sci. Med. 41(10), 1403-1409.
Yudofsky, S.C., &. Hales, R. E. (2006). Neuropsiquiatria e neurociências na prática clínica. (4. ed.) Porto Alegre: Artmed.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rafael Leite Fernandes; Ney Boa Sorte; Beatriz D’arck Santana Santos; Bruna Andrade Oliveira Brito; Lívia Navarro
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
